BINYAMINA, Israel, December 16, 2020 / PRNewswire / – Montfort (Mon4t), an innovative medical startup featuring its real-time remote neurological examiner.
Montfort’s FDA-cleared solution reduces smartphone, big data and AI technology to perform digital neuroscience tests for patients with conditions such as Parkinson’s disease, Huntington’s disease, psychiatric disorders (such as schizophrenia), as well as patients with Post-COVID19 symptoms, some of which are similar to those seen in brain conditions.
“Approximately one billion people worldwide suffer from brain and psychiatric disorders. Diagnostics and treatment are based on short and frequent clinical visits thus limiting and increasing the quality of patient care. handling costs – approx 800 billion USD in the US only, “he says Ziv Yekutieli, Montfort Co – Founder and CEO.
In the past few months, Montfort has been on a growing worldwide demand for the EncephaLog fuasgladh solution, which is used by hospitals, medical corporations, and research centers, particularly the Health System Henry Ford (US), Medtronic (US), The Queen’s Marriage hospital (Hong Kong), Campus Bio-Medico di Roma (Italy), and more.
“Before the pandemic, remote checkups were already gaining traction, locking COVID-19 made them inevitable. In addition, many countries are beginning to reimburse remote check costs, which provides a strong economic incentive for telemedicine. Our App allows routine neurological monitoring to be performed anytime, anywhere, using a standard smartphone, ”says Dr Yekutieli.
COVID-19 has increased demand for another reason: “For reasons that are not fully understood at this stage, the coronavirus is linked to a number of neurological symptoms that can have lasting effects,” he said. and Dr. Yekutieli. “Our platform now offers a Post-COVID-19 test protocol that covers relevant motor and mental functions.” In the last six months, Montfort has supplied Hospital of Clinicas de Porto Alegre into Brazil with a Remote Patient Monitoring (RPM) platform to monitor hundreds of health professionals with COVID-19.
The Montfort app comes in two versions: a clinical app for use by the doctor at the clinic, and a home version for patients to use in their natural environment. Its data collection and analysis, using Montfort and AI appropriateness algorithms, simplifies clinical study, faster patient diagnosis, and more efficient follow-up treatment.
Montfort was co – founded in Israel by Chief Ziv Yekutieli, PhD, an electrical engineer and brain scientist, with over 20 years of experience linking the two subjects; and Dima Gershman, CTO, Information Systems Engineering specialist. The Montfort advisory board includes Professor Patrick LeWitt, Professor of Neurology at Wayne State University School of Medicine, Parkinson’s Disease and Movement Disorder Program Director at Henry Ford Hospital, Michigan, USA. Professor Hagai Bergman, Chair of Brain Research, Faculty of Medical Sciences, Interdisciplinary Center for Neural Comparison, Center for Brain Research – Hebrew University, Senior Researcher, Department of Non – Surgery, Hadassah Medical Center, President – International Association of Basal Ganglia. Prof. Paul Friedmann, Professor of Clinical Neuroimmunology at Charité Universitätsmedizin Berlin, Germany.
Contact the media: